Clinical Trials
2 trialsNCT05809024 2023-04-12
Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy
Shandong Cancer Hospital and Institute
Phase 4 Unknown
NCT05749016 2023-03-01
Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown